Kairos Pharma to sell 1.55 million shares in IPO at $4 each
Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share.
Stay updated with breaking news from Corporate Changes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share.
By Anthony O. Goriainoff Dispensa Group said it intends to delist its ordinary shares from the U.K.'s Financial Conduct Authority's official list, and cancel...
By Anthony O. Goriainoff TUI booked record quarterly revenue, boosted by stronger customer demand, pushing the German travel company's shares higher even as...
The German airline plans to switch its listing to the Frankfurt Stock Exchange in June 2024
By Ian Walker and Elena Vardon TUI shareholders have approved the company's plan to delist from the London Stock Exchange, becoming the latest in a line of...